EC
PHXM

EcoR1 Capital’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

EcoR1 Capital’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,957
Closed -$590K – 62
2018
Q3 		$590K Sell
6,957
-8,439
-55% -$879K 0.05% 50
2018
Q2 		$1.73M Buy
+15,396
New +$2.89M 0.17% 31

Other funds holding PHXM

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EcoR1 Capital's PHXM Position: Q4 2018 in Review

EcoR1 Capital sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q4 2018, closing a stake of 6,957 shares — an estimated $590K sold.

EcoR1 Capital first reported a position in PHXM in Q2 2018 and held it in 2 quarters. The position peaked at $1.73M in Q2 2018. 5 funds tracked by Wall St. Rank hold PHXM as of Q4 2018.

  • EcoR1 Capital reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • EcoR1 Capital sold 6,957 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q4 2018, an estimated $590K.
  • EcoR1 Capital first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q2 2018 and held it in 2 quarters.
  • EcoR1 Capital's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $1.73M in Q2 2018.
  • 5 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q4 2018.

Based on EcoR1 Capital's 13F filing for Q4 2018, filed 14 Feb 2019.